|
Ambuja Cements Limited (AMBUJACEM.NS) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Ambuja Cements Limited (AMBUJACEM.NS) Bundle
Simplify Ambuja Cements Limited (AMBUJACEMNS) valuation with this customizable DCF Calculator! Featuring real Ambuja Cements Limited (AMBUJACEMNS) financials and adjustable forecast inputs, you can test scenarios and uncover Ambuja Cements Limited (AMBUJACEMNS) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2021 |
AY2 2022 |
AY3 2023 |
AY4 2024 |
AY5 2025 |
FY1 2026 |
FY2 2027 |
FY3 2028 |
FY4 2029 |
FY5 2030 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 240,938.6 | 285,480.8 | 310,369.9 | 327,341.9 | 336,977.0 | 366,982.3 | 399,659.3 | 435,246.0 | 474,001.4 | 516,207.7 |
| Revenue Growth, % | 0 | 18.49 | 8.72 | 5.47 | 2.94 | 8.9 | 8.9 | 8.9 | 8.9 | 8.9 |
| EBITDA | 54,608.8 | 65,471.0 | 36,222.9 | 61,654.4 | 86,034.3 | 74,596.9 | 81,239.2 | 88,473.0 | 96,350.8 | 104,930.1 |
| EBITDA, % | 22.67 | 22.93 | 11.67 | 18.83 | 25.53 | 20.33 | 20.33 | 20.33 | 20.33 | 20.33 |
| Depreciation | 11,617.8 | 11,524.9 | 12,483.9 | 16,308.2 | 24,783.4 | 18,509.0 | 20,157.1 | 21,951.9 | 23,906.6 | 26,035.3 |
| Depreciation, % | 4.82 | 4.04 | 4.02 | 4.98 | 7.35 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
| EBIT | 42,991.0 | 53,946.1 | 23,739.0 | 45,346.2 | 61,250.9 | 56,087.9 | 61,082.1 | 66,521.1 | 72,444.3 | 78,894.9 |
| EBIT, % | 17.84 | 18.9 | 7.65 | 13.85 | 18.18 | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 |
| Total Cash | 86,188.8 | 113,935.3 | 97,512.6 | 160,211.6 | 98,825.6 | 136,055.4 | 148,170.1 | 161,363.6 | 175,731.8 | 191,379.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 24,998.6 | 28,676.0 | .0 | 26,900.4 | 15,980.0 | 24,500.0 | 26,681.5 | 29,057.3 | 31,644.6 | 34,462.3 |
| Account Receivables, % | 10.38 | 10.04 | 0 | 8.22 | 4.74 | 6.68 | 6.68 | 6.68 | 6.68 | 6.68 |
| Inventories | 16,485.8 | 27,380.4 | 32,727.9 | 49,656.4 | 42,480.1 | 40,187.4 | 43,765.8 | 47,662.8 | 51,906.9 | 56,528.8 |
| Inventories, % | 6.84 | 9.59 | 10.54 | 15.17 | 12.61 | 10.95 | 10.95 | 10.95 | 10.95 | 10.95 |
| Accounts Payable | 22,134.1 | 29,128.2 | 27,739.1 | 31,087.5 | 27,594.6 | 33,772.0 | 36,779.1 | 40,054.0 | 43,620.5 | 47,504.6 |
| Accounts Payable, % | 9.19 | 10.2 | 8.94 | 9.5 | 8.19 | 9.2 | 9.2 | 9.2 | 9.2 | 9.2 |
| Capital Expenditure | -17,336.5 | -23,341.0 | -33,854.2 | -44,824.6 | -86,870.5 | -48,259.6 | -52,556.8 | -57,236.6 | -62,333.1 | -67,883.4 |
| Capital Expenditure, % | -7.2 | -8.18 | -10.91 | -13.69 | -25.78 | -13.15 | -13.15 | -13.15 | -13.15 | -13.15 |
| Tax Rate, % | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 |
| EBITAT | 25,476.7 | 38,764.1 | 17,941.8 | 27,594.7 | 43,100.8 | 37,906.2 | 41,281.5 | 44,957.3 | 48,960.4 | 53,320.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 407.7 | 19,370.1 | 18,510.9 | -41,402.2 | -4,382.5 | 8,105.7 | 6,129.0 | 6,674.7 | 7,269.1 | 7,916.3 |
| WACC, % | 5 | 5.01 | 5.02 | 5 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 31,220.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 8,233 | |||||||||
| Terminal Value | 816,632 | |||||||||
| Present Terminal Value | 639,604 | |||||||||
| Enterprise Value | 670,825 | |||||||||
| Net Debt | -42,548 | |||||||||
| Equity Value | 713,373 | |||||||||
| Diluted Shares Outstanding, MM | 2,457 | |||||||||
| Equity Value Per Share | 290.32 |
What You Will Receive
- Edit-Friendly Forecast Variables: Modify key assumptions (growth %, margins, WACC) effortlessly to explore various scenarios.
- Relevant Financial Data: Ambuja Cements Limited’s (AMBUJACEMNS) financial figures pre-inserted to accelerate your analysis.
- Automated DCF Calculations: The template automatically computes Net Present Value (NPV) and intrinsic value.
- Professional and Adaptable: A refined Excel model that customizes to fit your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Ambuja Cements Limited (AMBUJACEMNS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with customizable parameters for your analysis.
- Adjustable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to fit your projections.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios specific to Ambuja Cements Limited (AMBUJACEMNS).
- Interactive Dashboard and Charts: Visual representations provide a summary of key valuation metrics for simplified analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Ambuja Cements Limited (AMBUJACEMNS) data (historical and projected).
- Step 3: Modify key assumptions (yellow cells) based on your analysis.
- Step 4: Observe automatic recalculations for Ambuja Cements Limited’s intrinsic value.
- Step 5: Utilize the results for investment decisions or reporting.
Why Opt for This Calculator?
- Reliable Data: Utilize actual Ambuja Cements Limited (AMBUJACEMNS) financials for trustworthy valuation outcomes.
- Fully Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Efficient: Ready-made calculations save you from starting from the ground up.
- Professional Quality Tool: Crafted for investors, analysts, and consultants alike.
- User-Friendly Design: An intuitive interface with clear, step-by-step guidance ensures accessibility for all users.
Who Can Benefit from This Product?
- Cement Industry Students: Master valuation techniques and apply them with real-world data.
- Researchers: Integrate advanced models into your academic projects or studies.
- Investors: Validate your assumptions and evaluate valuation trends for Ambuja Cements Limited (AMBUJACEMNS).
- Financial Analysts: Enhance your efficiency with a customizable, pre-designed DCF model.
- Entrepreneurs: Learn how major public companies like Ambuja Cements Limited (AMBUJACEMNS) are assessed and valued.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Ambuja Cements Limited (AMBUJACEMNS), encompassing revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specific sheet dedicated to Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models illustrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Ambuja Cements Limited (AMBUJACEMNS).
- Dashboard and Charts: A visual summary of valuation outputs and assumptions for easier result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.